Studies demonstrate healing benefits across multiple organ systems, including tendons, ligaments, muscles, the gastrointestinal tract, blood vessels, nerves, and even brain tissue after injury
It was originally developed to stimulate the release of growth hormone (GH) from the anterior pituitary gland
Indeed, several meta-analyses have been performed to address this issue in recent years
We show (i) that PfGrx-catalyzed redox reactions outcompete uncatalyzed reactions between roGFP2 and GSH or GSSG by several orders of magnitude, (ii) that the PfGrx-catalyzed reduction and oxidation of roGFP2 occur via a mono- and not a dithiol mechanism, and (iii) that the reduction of roGFP2(S 2 ) as a model non-glutathione disulfide substrate most likely involves a rate-limiting glutathionylation in a ternary complex with a GSH molecule that is activated at the 1st glutathione-interaction site of PfGrx
ChIP-nexus enables improved detection of in vivo transcription factor binding footprints
This form is selected for its stability and bioavailability